The Q1 2025 financial report from MED indicates positive business performance metrics. Net revenue reached 150 billion VND, up 20% year-on-year. Net profit after tax was reported at 30 billion VND, an increase of 15%. This shows that MED is maintaining strong growth momentum. Key product segments such as pharmaceuticals and medical devices continue to perform well.
Additionally, the report indicates that operating costs have been effectively controlled, slightly decreasing compared to last year, which helps to enhance gross profit margins. The company has also developed new projects aimed at expanding the market and improving production capacity.
Despite facing challenges like raw material price fluctuations, MED is confident in achieving its 2025 revenue targets. Company leadership is committed to implementing sustainable development strategies while enhancing value for shareholders.
Leave a Reply